LTAS
USNA icon

Linden Thomas Advisory Services’s Usana Health Sciences USNA Stock Holding History

Linden Thomas Advisory Services’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,981
Closed -$220K – 492
2025
Q3 		$220K Sell
7,981
-78
-1% -$2.4K 0.02% 466
2025
Q2 		$246K Buy
+8,059
New +$229K 0.03% 441

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Linden Thomas Advisory Services's USNA Position: Q4 2025 in Review

Linden Thomas Advisory Services sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 7,981 shares — an estimated $220K sold.

Linden Thomas Advisory Services first reported a position in USNA in Q2 2025 and held it in 2 quarters. The position peaked at $246K in Q2 2025. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Linden Thomas Advisory Services reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Linden Thomas Advisory Services sold 7,981 Usana Health Sciences shares in Q4 2025, an estimated $220K.
  • Linden Thomas Advisory Services first reported a position in Usana Health Sciences in Q2 2025 and held it in 2 quarters.
  • Linden Thomas Advisory Services's Usana Health Sciences position peaked at $246K in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Linden Thomas Advisory Services's 13F filing for Q4 2025, filed 16 Jan 2026.